Editas Medicine downgraded to Market Perform from Outperform at Raymond James
The Fly

Editas Medicine downgraded to Market Perform from Outperform at Raymond James

Raymond James analyst Steven Seedhouse downgraded Editas Medicine (EDIT) to Market Perform from Outperform.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App